Citations

Clear

13584 citation(s) found for "_, _".

Key Factors, Effective Teamwork, and Healthcare Outcomes
Spaulding, Tony , Hobson, Charlie , Selladurai, Raj

Mayo Clinic

New Perspectives on Post-2020 Healthcare Reform | March 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: 223-250

10.4018/979-8-3373-2577-4.ch010 Get It

This chapter focuses on key factors that impact effective teamwork in healthcare organizations, including a case study on the applications of a teamwork model at Mayo Clinic in Rochester, MN. Studies have found positive correlations among effective teamwork, patient care, and provider satisfaction. Key factors such as teamwork training, leaderless online group discussion, servant leadership, and top management support lead to effective teamwork, which would positively impact the quadruple aim—patient experience, high-quality and safe delivery of patient care, lower costs, and provider satisfaction.
HSR26-214: Impact of Upper Gastrointestinal Bleeding on Mortality and Healthcare Utilization in Gastric Cancer Patients: A Real-World Evidence Analysis from the 2021 NIS Dataset
Maniar, Pranay, Dave, Bhoomi, Gunasignhe, Maduka, Rocchetti, Jenna, Thomas, Beje , Dave, Bhoomi

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7387 | PMID 41991110 Get It

PCO26-270: Transcriptomic Profiling Reveals Inflammatory and Epithelial-Mesenchymal Transition Pathway Activation in Endoxifen-Resistant Estrogen Receptor–Positive Breast Cancer
Remmel, H. Lawrence , Hawse, John R., Veviorsky, Alexander P., Zhavoronkov, Alex, Quay, S. C., Hammer, Sandra S. , Shneyderman, Anastasia , Veviorskiy, Alexander , Zhavoronkov, Alex , Quay, Steven C.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7152 | PMID 42055424 Get It

CLO26-130: Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Pancreatic Ductal Adenocarcinoma With Isolated Peritoneal Metastases: A Meta Analysis and Systematic Review
Ganatra, Nency, Abdel-Razeq, Nayef Hikmat, Kamatham, Saivaishnavi , Jain, Pragya , Patel, Shivam, Adeoye, Tayo, Khalil, Muhammad , Abdelhakeem, Ahmed , Elantably, Dina

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7202 | PMID 42061433 Get It

HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance)
Tevaarwerk, A. J., Campbell, Nancy, Emamekhoo, Hamid, Chow, Selina , Elrahi, Cassandra , Commers, Winnie, Birgin, Alisha, Galanis, E., Piantadosi, Steven , Tevaarwerk, Amye J., Emamekhoo, Hamid

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7420 | PMID 42055437 Get It

HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study
Miller, R., Graham, William E., Kang, Paul , Graff, Jordan M., Miller, Richard Max, Barakat, Mark

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7166 | PMID 42055049 Get It

CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy
Stringer-Reasor, Erica, Li, Yufeng , Zhang, Jianqing , Rocque, Gabrielle, Jones, Kyla R, O'Sullivan, C. C., Dees, Elizabeth Claire , Nanda, Rita, Hunter, Natasha, Clark, Amy S. , Wolff, Antonio, Krop, Ian E. , Lin, Nancy, Yang, Eddy S. , O'Sullivan, Ciara, Giridhar, Karthik, Stringer-Reasor, Erica , Rocque, Gabrielle B. , O’Sullivan, Ciara C. , Giridhar, Karthik V. , Hunter, Natasha B. , Wolff, Antonio C. , Rimawi, Mothaffar F.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7190 | PMID 42061438 Get It

CGE26-141: Circulating Tumor DNA as a Prognostic Biomarker Across Postoperative, Post-Adjuvant, and Surveillance Windows in Localized Colorectal Cancer
Ganatra, Nency, Jain, Pragya , Patel, Shivam , Adeoye, Tayo, Elantably, Dina, Chovatiya, Juhi , Tahir, Naqvi, Abdelhakeem, Ahmed

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7246 | PMID 41990786 Get It

CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study
Sun, C, Han, Yiqun, Fickel, Abigail, Liu, Li , Lees, Elizabeth , Lees, Elizabeth H.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available

10.6004/jnccn.2025.7465 | PMID 42061454 Get It

Efficacy, Safety, and Net Clinical Benefit of Post‐Atrial Fibrillation Ablation Anticoagulation
Abomohsen, Mustafa , Mohamed, Ahmed , Almakadma, Abdul Hakim , Mojahedi, Azad , Kholeif, Zeyad , Elalfy, A E, Shams, Mahmoud M. , Gadelmawla, Ahmed Farid , Tahhan, Imad Samman , Elnashar, Mohab, Rashwan, Rana , Elnady, Mohamed , Gunsburg, Moshe, Gadelmawla, Ahmed Farid , Mohamed, Ahmed Elmorsy , Tahhan, Imad , Elalfy, Aya, Elnashar, Mohab

Mayo Clinic

Pacing and Clinical Electrophysiology | March 27, 2026 | Volume: 49 | Issue: 5 | Pages: 590-601

10.1111/pace.70224 | PMID 41889075 Get It

ABSTRACT Background The optimal long‐term antithrombotic strategy after apparently successful catheter ablation of atrial fibrillation (AF) remains uncertain, particularly in patients who meet conventional guideline thresholds for oral anticoagulation (OAC). Objectives To compare continuation versus cessation strategies of long‐term OAC after successful AF ablation and to quantify net clinical benefit (NCB) integrating thromboembolic and bleeding outcomes. Methods We searched PubMed, Cochrane CENTRAL, and Embase from inception through February 2026 for randomized and comparative observational studies evaluating long‐term OAC continuation versus cessation (no OAC and/or switch to aspirin) after successful AF ablation. Risk of bias was assessed using RoB2 for randomized trials and a modified Newcastle–Ottawa Scale (NOS) for observational studies. Random‐effects meta‐analyses used a restricted maximum likelihood estimator with Hartung–Knapp adjustment. NCB was calculated as: thromboembolic event rate − (1.5 × major bleeding rate). Results Six studies met the inclusion criteria (four randomized trials and two observational cohorts). Stroke/transient ischemic attack (TIA) events were reported in six studies and were not significantly different between OAC continuation and cessation strategies (OR 0.69; 95% CI 0.24–1.99; p = 0.49). Systemic embolism (three studies) did not differ between groups ( p = 0.12). Major bleeding (five studies) was numerically higher with continued OAC but not statistically significant (OR 2.07; 95% CI 0.88–4.86; p = 0.09). In NCB analysis, continued OAC yielded more negative or near‐neutral NCB values, whereas, the cessation strategies were less negative or marginally positive; the fixed‐effect risk difference in NCB (continued OAC vs cessation) was +0.00067 (95% CI −0.00279 to +0.00413). Conclusion This meta‐analysis suggests that after successful AF ablation, continuing OAC does not significantly reduce stroke risk compared to cessation or switching to aspirin, but it may increase major bleeding. While NCB trends favor cessation, the low absolute event rates and the risk of silent AF recurrence necessitate caution.